{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:47:59Z","timestamp":1780584479183,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.parkreldis.2023.105939","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T17:31:51Z","timestamp":1700760711000},"page":"105939","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Estimating the sequence of biomarker changes in Parkinson's disease"],"prefix":"10.1016","volume":"118","author":[{"given":"Yaqin","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiuRong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0909-6582","authenticated-orcid":false,"given":"Yase","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxiang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beisha","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jifeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10291","key":"10.1016\/j.parkreldis.2023.105939_bib1","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2023.105939_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2022.105327","article-title":"Restoration and targeting of aberrant neurotransmitters in Parkinson's disease therapeutics","volume":"156","author":"Yadav","year":"2022","journal-title":"Neurochem. Int."},{"issue":"2","key":"10.1016\/j.parkreldis.2023.105939_bib3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2174\/1570159X16666180302115032","article-title":"Insight into the emerging role of striatal neurotransmitters in the pathophysiology of Parkinson's disease and huntington's disease: a review","volume":"17","author":"Jamwal","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.parkreldis.2023.105939_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40035-019-0165-9","article-title":"The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson's disease","volume":"8","author":"Pang","year":"2019","journal-title":"Transl. Neurodegener."},{"issue":"9996","key":"10.1016\/j.parkreldis.2023.105939_bib5","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2023.105939_bib6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lfs.2019.03.057","article-title":"Parkinson's disease: mechanisms, translational models and management strategies","volume":"226","author":"Raza","year":"2019","journal-title":"Life Sci."},{"issue":"Pt 5","key":"10.1016\/j.parkreldis.2023.105939_bib7","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson's disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.parkreldis.2023.105939_bib8","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.21995","article-title":"Clinical progression in Parkinson disease and the neurobiology of axons","volume":"67","author":"Cheng","year":"2010","journal-title":"Ann. Neurol."},{"issue":"14","key":"10.1016\/j.parkreldis.2023.105939_bib9","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/mds.25975","article-title":"Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts","volume":"29","author":"Kraemmer","year":"2014","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.parkreldis.2023.105939_bib10","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/mds.26578","article-title":"Longitudinal measurements of cerebrospinal fluid biomarkers in Parkinson's disease","volume":"31","author":"Hall","year":"2016","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2023.105939_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuron.2016.06.030","article-title":"Neurofilament light: a dynamic cross-disease fluid biomarker for neurodegeneration","volume":"91","author":"Zetterberg","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.parkreldis.2023.105939_bib12","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.neuroimage.2018.11.024","article-title":"Disease progression timeline estimation for Alzheimer's disease using discriminative event based modeling","volume":"186","author":"Venkatraghavan","year":"2019","journal-title":"Neuroimage"},{"issue":"3","key":"10.1016\/j.parkreldis.2023.105939_bib13","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/brain\/awaa461","article-title":"Sequence of clinical and neurodegeneration events in Parkinson's disease progression","volume":"144","author":"Oxtoby","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2023.105939_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2020.117646","article-title":"Analyzing the effect of APOE on Alzheimer's disease progression using an event-based model for stratified populations","volume":"227","author":"Venkatraghavan","year":"2021","journal-title":"Neuroimage"},{"issue":"5","key":"10.1016\/j.parkreldis.2023.105939_bib15","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/brain\/awab382","article-title":"A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia","volume":"145","author":"van der Ende","year":"2022","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.parkreldis.2023.105939_bib16","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/jnnp-2020-323541","article-title":"Modelling the cascade of biomarker changes in -related frontotemporal dementia","volume":"92","author":"Panman","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.parkreldis.2023.105939_bib17","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/acn3.51035","article-title":"Evolution of white matter damage in amyotrophic lateral sclerosis","volume":"7","author":"Gabel","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"10.1016\/j.parkreldis.2023.105939_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac098","article-title":"A data-driven model of brain volume changes in progressive supranuclear palsy","volume":"4","author":"Scotton","year":"2022","journal-title":"Brain Commun"},{"key":"10.1016\/j.parkreldis.2023.105939_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2020.102550","article-title":"The sequence of structural, functional and cognitive changes in multiple sclerosis","volume":"29","author":"Dekker","year":"2021","journal-title":"Neuroimage Clin"},{"issue":"12","key":"10.1016\/j.parkreldis.2023.105939_bib20","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/acn3.644","article-title":"The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort","volume":"5","author":"Marek","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"10.1016\/j.parkreldis.2023.105939_bib21","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","volume":"95","author":"The Parkinson Progression Marker Initiative (Ppmi)","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.parkreldis.2023.105939_bib22","doi-asserted-by":"crossref","DOI":"10.1177\/17562864221092566","article-title":"Association between cigarette smoking and Parkinson's disease: a neuroimaging study","volume":"15","author":"Wang","year":"2022","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.parkreldis.2023.105939_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105668","article-title":"Gender differences in dopaminergic system dysfunction in de novo Parkinson's disease clinical subtypes","volume":"167","author":"Boccalini","year":"2022","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.parkreldis.2023.105939_bib24","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3233\/JPD-212535","article-title":"Serum Neurofilament Dynamics Predicts Cognitive Progression in de novo Parkinson's Disease","volume":"11","author":"Ma","year":"2021","journal-title":"J. Parkinsons Dis."},{"issue":"9","key":"10.1016\/j.parkreldis.2023.105939_bib25","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/mds.27806","article-title":"Longitudinal analyses of cerebrospinal fluid \u03b1-Synuclein in prodromal and early Parkinson's disease","volume":"34","author":"Mollenhauer","year":"2019","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.parkreldis.2023.105939_bib26","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.23821","article-title":"Association of cerebrospinal fluid neurofilament heavy protein levels with clinical progression in patients with Parkinson disease","volume":"5","author":"Wang","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"7","key":"10.1016\/j.parkreldis.2023.105939_bib27","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/mdc3.13533","article-title":"Prevalence and incidence of nonmotor symptoms in individuals with and without Parkinson's disease","volume":"9","author":"Paracha","year":"2022","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"10","key":"10.1016\/j.parkreldis.2023.105939_bib28","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1093\/brain\/awab191","article-title":"The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson's disease","volume":"144","author":"Biondetti","year":"2021","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.parkreldis.2023.105939_bib29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41531-021-00250-2","article-title":"Genetic factors affecting dopaminergic deterioration during the premotor stage of Parkinson disease","volume":"7","author":"Lee","year":"2021","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.parkreldis.2023.105939_bib30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.parkreldis.2022.08.006","article-title":"Temporal trajectory model for dopaminergic input to the striatal subregions in Parkinson's disease","volume":"103","author":"Kim","year":"2022","journal-title":"Parkinsonism Relat. Disorders"},{"issue":"5","key":"10.1016\/j.parkreldis.2023.105939_bib31","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ana.22284","article-title":"Age-specific progression of nigrostriatal dysfunction in Parkinson's disease","volume":"69","author":"de la Fuente-Fern\u00e1ndez","year":"2011","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.parkreldis.2023.105939_bib32","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/mds.1139","article-title":"Rate of progression in Parkinson's disease: a 6-[18F]fluoro-L-dopa PET study","volume":"16","author":"Nurmi","year":"2001","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2023.105939_bib33","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00441-018-2832-z","article-title":"Lateralisation in Parkinson disease","volume":"373","author":"Riederer","year":"2018","journal-title":"Cell Tissue Res."},{"issue":"14","key":"10.1016\/j.parkreldis.2023.105939_bib34","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJM198804073181402","article-title":"Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications","volume":"318","author":"Kish","year":"1988","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.parkreldis.2023.105939_bib35","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1136\/jnnp.64.3.314","article-title":"Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET","volume":"64","author":"Morrish","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"7","key":"10.1016\/j.parkreldis.2023.105939_bib36","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.parkreldis.2015.04.027","article-title":"Amyloid-\u03b2 and \u03b1-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson's disease","volume":"21","author":"Stav","year":"2015","journal-title":"Parkinsonism Relat. Disorders"},{"issue":"10","key":"10.1016\/j.parkreldis.2023.105939_bib37","first-page":"1277","article-title":"Association of cerebrospinal fluid \u03b2-amyloid 1-42, T-tau, P-tau181, and \u03b1-synuclein levels with clinical features of drug-naive patients with early Parkinson disease","volume":"70","author":"Kang","year":"2013","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2023.105939_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94345-8","article-title":"Temporal trajectory of biofluid markers in Parkinson's disease","volume":"11","author":"Baek","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.parkreldis.2023.105939_bib39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.parkreldis.2023.105939_bib40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.parkreldis.2009.08.007","article-title":"A timeline for Parkinson's disease","volume":"16","author":"Hawkes","year":"2010","journal-title":"Parkinsonism Relat. Disorders"},{"issue":"4","key":"10.1016\/j.parkreldis.2023.105939_bib41","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/jamaneurol.2017.4243","article-title":"When do \u03b1-synucleinopathies start? An epidemiological timeline: a review","volume":"75","author":"Savica","year":"2018","journal-title":"JAMA Neurol."},{"issue":"6608","key":"10.1016\/j.parkreldis.2023.105939_bib42","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.add7162","article-title":"Toward preventing Parkinson's disease","volume":"377","author":"Mollenhauer","year":"2022","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.parkreldis.2023.105939_bib43","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/mds.28026","article-title":"Intraindividual neurofilament dynamics in serum mark the conversion to sporadic Parkinson's disease","volume":"35","author":"Wilke","year":"2020","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.parkreldis.2023.105939_bib44","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1002\/mds.28206","article-title":"Validation of serum neurofilament light chain as a biomarker of Parkinson's disease progression","volume":"35","author":"Mollenhauer","year":"2020","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.parkreldis.2023.105939_bib45","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(19)30024-9","article-title":"CSF and blood biomarkers for Parkinson's disease","volume":"18","author":"Parnetti","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2023.105939_bib46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.parkreldis.2021.04.016","article-title":"Plasma NfL, clinical subtypes and motor progression in Parkinson's disease","volume":"87","author":"Pilotto","year":"2021","journal-title":"Parkinsonism Relat. Disorders"},{"issue":"11","key":"10.1016\/j.parkreldis.2023.105939_bib47","doi-asserted-by":"crossref","first-page":"e1104","DOI":"10.1212\/WNL.0000000000008088","article-title":"Blood NfL: a biomarker for disease severity and progression in Parkinson disease","volume":"93","author":"Lin","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2023.105939_bib48","article-title":"Neurofilament light as a biomarker for motor decline in Parkinson's disease","volume":"16","author":"Liu","year":"2022","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.parkreldis.2023.105939_bib49","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3233\/JPD-181517","article-title":"Revision of diagnosis in early parkinsonism with abnormal dopamine transporter imaging","volume":"9","author":"Massa","year":"2019","journal-title":"J. Parkinsons Dis."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802023010180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802023010180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:29:05Z","timestamp":1761179345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802023010180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":49,"alternative-id":["S1353802023010180"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105939","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimating the sequence of biomarker changes in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105939","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105939"}}